The companies have been accused of violating antitrust laws by fixing prices and allocating customers.
Net Sales are expected to increase by 12.7 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 4,888 crore, according to Sharekhan.
Net Sales are expected to increase by 6.3 percent Y-o-Y (up 10.9 percent Q-o-Q) to Rs. 4,714 crore, according to Sharekhan.
Net Sales are expected to increase by 19 percent Y-o-Y to Rs. 4,334.4 crore, according to Edelweiss.
Axis Direct is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 16, 2017.
HDFC Securities is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 30, 2017.
Net Sales are expected to increase by 4.6 percent Q-o-Q (up 9.1 percent Y-o-Y) to Rs 4087.6 crore, according to ICICI Securities. Aurobindo to report net profit at 616.2 crore up 6.5% quarter-on-quarter.
Benchmark indices and broader markets remained under pressure amid volatility in morning trade. GAIL and Aurobindo Pharma were the biggest gainers, up more than 2 percent.
Equity benchmarks as well as broader markets remained rangebound in noon trade with the Sensex hovering around 26500 level. Technology stocks continued to support the market whereas selling pressure was seen in banks, FMCG, select metals and pharma stocks.
The market continued to consolidate with the Nifty gyrating in a range of 8130-8150 in morning. ITC and ICICI Bank were the leading contributors while Infosys and HDFC continued to support the market.
Lupin and Tata Motors were top gainers in early trade, up 2 percent each followed by Sun Pharma, BHEL, Hero MotoCorp and Aurobindo Pharma while Tata Steel, ITC, ONGC, Bharti Airtel, ICICI Bank, Idea Cellular and Bharti Infratel were losers.
Jubilant Foodworks was the most active stock on exchanges after CSR report saying the bread available in India could be laced with toxic chemicals and may have toxic chemicals that can lead to thyroid disorders and cancer.
ICICI Bank, NTPC, Adani Ports, Bharti Airtel and Dr Reddy's Lab are the top losers, while Hindalco, Cipla, Reliance Industries, Lupin, Coal India and Aurobindo Pharma are top gainers.
Emkay Global Financial Services has come out with its report on Pharmaceuticals sector. The research firm has preferred Glenmark, Aurobindo, Cadila and Lupin from the space.
Aurobindo Pharma, Tata Motors, Cipla, Asian Paints, Aban Offshore, TCS, Bharti Airtel and HCL Technologies are most active shares on exchanges.
Aban Offshore and Aurobindo Pharma are among the most active shares on exchanges ahead of December quarter earnings today. Jet Airways topped the most active list after Etihad received aproval from CCI to buy 50.1 percent stake in Jet Privilege; the stock surged 10 percent.
Manav Chopra of Nirmal Bang advises buying Dish TV for a target price of 63 and Jubilant Foodworks for a target price of Rs 1,390.
Dharmesh Kant of India Nivesh Securities advises buying Aurobindo Pharma for a target price of Rs 320 and Alembic Pharma for a target price of Rs 215.
Sharmila Joshi of Peerless Securities advises buying Sintex Industries for a target price of Rs 31.30 and VIP Industries for a target price of Rs 61.
Kunal Bothra of LKP Shares advises buying Finolex Cables for a target price of Rs 78 and Indiabulls Housing Finance for a target price of Rs 228.
Gold is set for its second weekly loss while oil saw Brent traded at the lowest level it has seen in July.
Global biopharma company, UCB filed separate cases against 15 drug makers including Ranbaxy, Aurobindo, Zydus, Sun Pharma, Glenmark, Alembic Pharmaceuticals.
Aurobindo Pharma gets tentative approval from the US FDA to manufacture and market efavirenz, lamivudine and tenofovir disoproxil fumarate tablets used for treating a type of HIV infection.
Essel Propack | GAIL | Reliance Power | Fortis Healthcare | Aurobindo Pharma | Redington | Coal India | Ranbaxy Labs | RPG Life | Claris Life and Mahindra Satyam are stocks, which are in the news today.
Pharma stocks like Dr Reddy, Divis Lab, Aurobindo, Lupin, tyre stocks like Apollo, MRF, JK Tyre and Personal care stocks like Colgate, Hindustan Unilever Dabur will be getting astrological support, says Satish Gupta of Astrostocktips.